Nerve-Freezing Technique Staves Off Post-Mastectomy Pain Percutaneous cryoneurolysis improved analgesia in a pilot study Oct 24, 2022
Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancer "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggests Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancer Risk is low but appears to have modifiable components Oct 13, 2022
Katie Couric's Breast Cancer The popular media personality is on a mission to raise awareness around dense breasts Oct 06, 2022
Hand Cooling, Compression Both Effective for Nerve Pain in Breast Cancer But access, cost, and tolerability may favor the latter option, said researcher Sep 14, 2022
Denosumab Halts Bone Loss From Ovarian Suppression, AIs for Breast Cancer Areal BMD increased when given at the start of maximal estradiol depletion therapy Sep 13, 2022
Targeted Combo Flops as First-Line Treatment in Advanced Breast Cancer No clinical benefit boost with anti-CD73 oleclumab added to durvalumab and chemo Sep 10, 2022
Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancer Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing Sep 09, 2022
2 Years of Endocrine Therapy, 2 Decades of Protection From Metastatic Breast Cancer Tamoxifen protects low-risk premenopausal patients, goserelin helps high-risk patients Aug 31, 2022
Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemo Ototoxicity reported in more than half of study patients who got platinum, taxanes, or both Aug 03, 2022
Lessons From a Lifelong Patient Turned Oncologist Eric Winer, MD, talks about how growing up with hemophilia helped him connect with patients Aug 02, 2022 podcast
Do Therapy-Related Hot Flashes in Breast Cancer Signal Worse Outcomes? Swedish study finds reduced DFS in women who used drugs for hot flashes Jun 22, 2022
Diabetes Threatens Long-Term Survival in Metastatic Breast Cancer 5-year survival rates were not affected, however Jun 13, 2022
A Better Way to Irradiate Lethal CNS Metastases? Randomized trial makes case for proton craniospinal irradiation for leptomeningeal spread Jun 08, 2022
Forego Radiotherapy for Women With Low-Risk Luminal A Breast Cancer? Study shows 5-year local recurrence rate of 2.3% with lumpectomy and endocrine therapy alone Jun 07, 2022
Endocrine Switch Plus Ribociclib Active in Post-CDK4/6 Inhibitor Progression First randomized support for strategy in progressive metastatic HR+/HER2- breast cancer Jun 06, 2022
Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancer DESTINY-Breast04 extends agent's benefits to historically tough-to-treat disease Jun 05, 2022
Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancer But benefit seems to be predominantly in patients with PI3K/AKT/PTEN pathway alterations Jun 05, 2022
Sacituzumab Govitecan Boosts PFS in Late-Line HR+/HER2- Metastatic Breast Cancer "This may be something that really changes the lives of these women for the better," expert says Jun 05, 2022
Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer More than half of everolimus-treated patients permanently discontinued treatment Jun 02, 2022
Prone Beats Supine Positioning for WBRT in Women With Large Breasts Prone position led to lower rates of moist desquamation May 27, 2022
Black Patients Often Never Given a Chance to Join Breast Cancer Trials But survey finds several actionable findings that could boost enrollment May 26, 2022
Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancer Prescribing rate is half that of women with no breast cancer history May 13, 2022
Novel Combo Falters in Metastatic Triple-Negative Breast Cancer No PFS benefit with addition of ceralasertib to olaparib May 05, 2022
Screening, Early Detection Remain Keys to Lower Cancer Mortality Presidential panel sets course to remove barriers, increase services, and improve uptake May 05, 2022
Antibody-Drug Conjugate Promising for Breast Cancer With Brain Mets High intracranial response rates with trastuzumab-deruxtecan observed in TUXEDO-1 trial May 04, 2022
Young Cancer Survivors Face Higher Risk of Death From Second Malignancies Study finds 25% higher risk of secondary cancers versus general public, 84% higher risk of death May 04, 2022
Menstrual Cycles Point to Link Between Sex Hormones and Long QT Research suggests new tools for risk stratification and therapy May 01, 2022
DCIS Recurrence Often Represents a New Primary Breast Cancer Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
RT Prior to Mastectomy, Reconstruction Shows Promise U.K. study demonstrates low complication rates and good aesthetic results Apr 08, 2022
Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomy Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
3D Mammograms Deliver Fewer False-Positive Findings However, half of women will have a false positive with annual screening with DBT Mar 25, 2022
Artificial Sweeteners Not So Sweet When It Comes to Cancer Risk Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancer Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
Fluorescence-Guided Lumpectomy Shows Promise Imaging system reduced the need for re-excision in one-fifth of patients Mar 11, 2022
Androgen Receptor Agonist Active in Resistant ER+ Breast Cancer Also: Combination targets uncommon form of advanced HER2-mutant disease Mar 09, 2022
More Options for Precision Medicine in Metastatic Triple-Negative Breast Cancer Moving beyond chemotherapy to immunotherapy, PARP inhibitors, ADCs, combinations Mar 08, 2022
Chipping Away at the Dogma of Axillary Dissection in Breast Cancer Ongoing trials could help some women avoid even less-invasive sentinel lymph node biopsy Mar 07, 2022